Aethlon Medical (Common Stock) ownership update: Alumni Capital LP, Alumni Capital GP LLC and Ashkan Mapar report shared beneficial ownership of 55,555 shares, representing 4.05% of the class. The shares relate to rights under a Securities Purchase Agreement dated September 4, 2025 and a Common Warrant dated September 4, 2025. The percent of class is calculated using 1,315,110 Shares outstanding as of February 11, 2026 as referenced in the issuer's Form 10-Q. The filing states that as of February 12, 2026 the Reporting Persons do not beneficially own more than five percent of the outstanding Shares.
Positive
None.
Negative
None.
Insights
Alumni Capital reports a 4.05% shared stake tied to purchase agreement and warrant.
The filing lists 55,555 shares attributable to Alumni Capital LP, Alumni Capital GP LLC and Ashkan Mapar, with shared voting and dispositive power. These shares "may be acquired" under a Securities Purchase Agreement and an accompanying Common Warrant dated September 4, 2025.
Ownership percentage uses the issuer's disclosure of 1,315,110 Shares outstanding as of February 11, 2026. The filing preserves the qualifier that the shares are contingent on the agreement/warrant terms; timing and exercise conditions are not stated in the excerpt.
Amendment clarifies beneficial ownership and joint filing attribution.
The statement is a joint filing—Alumni Capital LP, Alumni Capital GP LLC and Ashkan Mapar are named as Reporting Persons and sign the amendment. Shared voting and dispositive power of 55,555 shares is attributed across the entities.
Qualifier language ties the reported amount to the Purchase Agreement and Common Warrant; the filing notes the Reporting Persons remain below the 5% threshold as of February 12, 2026.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)
AETHLON MEDICAL INC
(Name of Issuer)
Common Stock
(Title of Class of Securities)
00808Y505
(CUSIP Number)
10/31/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
00808Y505
1
Names of Reporting Persons
Alumni Capital LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
55,555.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
55,555.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
55,555.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.05 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP No.
00808Y505
1
Names of Reporting Persons
Alumni Capital GP LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
55,555.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
55,555.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
55,555.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.05 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP No.
00808Y505
1
Names of Reporting Persons
Ashkan Mapar
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
55,555.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
55,555.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
55,555.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.05 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
AETHLON MEDICAL INC
(b)
Address of issuer's principal executive offices:
11555 Sorrento Valley Road, Suite 203, San Diego, California 92121
Item 2.
(a)
Name of person filing:
This statement is filed by Alumni Capital LP (the "Fund"), Alumni Capital GP LLC (the "General Partner"), and Ashkan Mapar (the "Controlling Person"). The foregoing are collectively referred to herein as the "Reporting Persons".
The Fund holds, has the right to acquire, or has the obligation to acquire, securities of the Issuer. The General Partner serves as the general partner of the Fund. The Controlling person is the control person of the General Partner.
(b)
Address or principal business office or, if none, residence:
The address for the principal business office of each of Alumni Capital LP, Alumni Capital GP LLC, and Ashkan Mapar is 601 Brickell Key Dr., Suite 700, Miami, FL 33131.
(c)
Citizenship:
Alumni Capital LP is a Delaware limited partnership. Alumni Capital GP LLC is a Delaware limited liability company. Ashkan Mapar is a citizen of the United States of America.
(d)
Title of class of securities:
Common Stock
(e)
CUSIP No.:
00808Y505
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
Alumni Capital LP - 55,555*
Alumni Capital GP LLC - 55,555*
Ashkan Mapar - 55,555*
*The shares of common stock (the "Shares") of Aethlon Medical, Inc. (the "Issuer") reported herein represent Shares that may be acquired by Alumni Capital LP (the "Fund") pursuant to (i) a Securities Purchase Agreement dated September 4, 2025, between the Issuer and the Fund (the "Purchase Agreement") and (ii) a warrant to purchase common stock dated September 4, 2025 (the "Common Warrant").
The percent of class reported herein is based upon the Issuer's representation in its Quarterly Report on Form 10-Q filed with the SEC on February 12, 2026 that there were 1,315,110 Shares outstanding as of February 11, 2026 plus the approximate total number of Shares that the Reporting Persons may acquire upon exercise of outstanding Common Warrants.
As of February 12, 2026, the Reporting Persons do not beneficially own more than five percent of the outstanding Shares of the Issuer.
(b)
Percent of class:
Alumni Capital LP - 4.05%
Alumni Capital GP LLC - 4.05%
Ashkan Mapar - 4.05%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Alumni Capital LP - 0
Alumni Capital GP LLC - 0
Ashkan Mapar - 0
(ii) Shared power to vote or to direct the vote:
Alumni Capital LP - 55,555*
Alumni Capital GP LLC - 55,555*
Ashkan Mapar - 55,555*
(iii) Sole power to dispose or to direct the disposition of:
Alumni Capital LP - 0
Alumni Capital GP LLC - 0
Ashkan Mapar - 0
(iv) Shared power to dispose or to direct the disposition of:
Alumni Capital LP - 55,555*
Alumni Capital GP LLC - 55,555*
Ashkan Mapar - 55,555*
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Alumni Capital LP
Signature:
/s/ Ashkan Mapar
Name/Title:
Ashkan Mapar, Manager of Alumni Capital GP LLC, General Partner of Alumni Capital LP
Date:
02/17/2026
Alumni Capital GP LLC
Signature:
/s/ Ashkan Mapar
Name/Title:
Ashkan Mapar, Manager of Alumni Capital GP LLC, General Partner of Alumni Capital LP
Date:
02/17/2026
Ashkan Mapar
Signature:
/s/ Ashkan Mapar
Name/Title:
Ashkan Mapar, Manager of Alumni Capital GP LLC, General Partner of Alumni Capital LP
Alumni Capital reports shared beneficial ownership of 55,555 shares, equal to 4.05% of common stock. The percentage uses the issuer's reported 1,315,110 Shares outstanding as of February 11, 2026 and includes shares tied to agreement/warrant rights.
Are the 55,555 shares currently owned or contingent for AEMD?
The 55,555 shares are reported as shares that may be acquired pursuant to a Securities Purchase Agreement and a Common Warrant, both dated September 4, 2025. The filing links ownership to those instruments rather than stating open-market holdings.
Does the filing say Alumni Capital exceeds 5% of AEMD stock?
No. The filing states that as of February 12, 2026 the Reporting Persons do not beneficially own more than five percent of the outstanding shares, and it reports the calculated 4.05% figure.
Who are the Reporting Persons in this 13G/A for AEMD?
The joint filing is made by Alumni Capital LP, its general partner Alumni Capital GP LLC, and Ashkan Mapar as the controlling person. The principal business address is listed as 601 Brickell Key Dr., Suite 700, Miami, FL 33131.
What source does the filing use to calculate the percent of AEMD class?
The percent of class is based on the issuer's representation in its Form 10-Q that there were 1,315,110 Shares outstanding as of February 11, 2026, together with the approximate number of shares issuable upon exercise of outstanding Common Warrants.
